Sign in

CIK 0000897448

  • Accelerated filer

AMARIN CORP PLCUK

Sign in to watch
Ticker
AMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+353 16699020
Business address
SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
Former names
AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-10 STACK DAVID M Director Option exercise +28,500 $1.87 $53K 87,000
2019-01-10 STACK DAVID M Director Option exercise +11,572 $2.50 $29K 98,572
2019-01-10 STACK DAVID M Director Sale −98,572 $18.00 $1.8M 0
2019-01-10 STACK DAVID M Director Option exercise · Stock Option (Right to Buy) −5,786 11,572
2019-01-10 STACK DAVID M Director Option exercise · Stock Option (Right to Buy) −21,146 0
2019-01-10 STACK DAVID M Director Option exercise · Stock Option (Right to Buy) −45,000 0
2019-01-10 STACK DAVID M Director Option exercise · Stock Option (Right to Buy) −13,500 0
2019-01-10 STACK DAVID M Director Option exercise · Stock Option (Right to Buy) −28,500 0
2019-01-10 STACK DAVID M Director Option exercise · Stock Option (Right to Buy) −11,572 0
2019-01-10 Ekman Lars Director Option exercise +100,416 $1.03 $103K 140,416
2019-01-10 Ekman Lars Director Sale −21,200 $14.92 $316K 119,216
2019-01-10 Ekman Lars Director Sale −7,247 $15.96 $116K 111,969
2019-01-10 Ekman Lars Director Sale −48,711 $17.29 $842K 63,258
2019-01-10 Ekman Lars Director Sale −55,762 $18.16 $1.0M 7,496
2019-01-10 Ekman Lars Director Sale −7,496 $18.62 $140K 0
2019-01-10 Ekman Lars Director Option exercise · Stock Option (Right to Buy) −100,416 19,584
2019-01-09 Kalb Michael Wayne SVP and CFO Option exercise +200,000 $2.19 $438K 217,486
2019-01-09 Kalb Michael Wayne SVP and CFO Sale −200,000 $15.26 $3.1M 17,486
2019-01-09 Kalb Michael Wayne SVP and CFO Option exercise · Stock Option (Right to Buy) −200,000 275,000
2019-01-02 Zakrzewski Joseph S Director Option exercise +350,000 $3.40 $1.2M 434,547

Page 76 of 95 · 1,885 trades